ApoE & Alzheimer’s disease: can genetic testing inform clinical practice?
Using a clinical precision medicine strategy that incorporates ApoE4 carrier status may provide a highly targeted approach to Alzheimer’s disease prevention.
Dr Isaacson has received honoraria/consultation fees from Neurotrack.